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             The chemical constituents of Toussantia orientalis and T. patriciae (Annonaceae) leaf extracts were 
evaluated for their antiviral activities in ovo against Infectious Bursal Disease Virus (IBDV) and Newcastle 
Disease Virus (NDV). The nine-day-old embryonated eggs in a set of five were used for testing through the 
allantoic route inoculation assay for each tested compound and controls. For NDV assay, the allantoic fluids 
from the specimens were further harvested to determin  viral contagion. The tested compounds exhibited 
potency with varying levels of significance at a screening concentration of 360 µg/ml against the two viral 
strains. Embryos infected with IBDV survived, grew to normal size with complete organ formation and had
mean weights comparable to those of the uninfected on s when treated with the aminocinnamoyl tetraketides 1, 
2, and 4, glucosylflavonoid 7 from T. orientalis and ursolic acid derivatives 9 and 10 from T. patriciae 
demonstrating high efficacy against IBDV. The compounds also exhibited antiviral activity against NDV, 
showing viral titre reduction ranging from 1:16 - 1:256 in the haemagglutination test, with compound 11 
having the lowest titre value (1:16) followed by compound 7 (1:32). The compounds that exhibited significant 
antiviral efficacy could be considered potential leds for the development of antiviral agents.  
© 2014 International Formulae Group. All rights reserved. 
 





Poultry production in Tanzania and 
other low income countries is dominated by 
the free-range local chickens (FRLC) forming 
one of the major economic activities for 
majority of the people living in the rural areas. 
It has been established that rural poultry 
industry contributes significantly to improving 
income at household levels (Kisungwe et al., 
2012; Moreki, 2013). The industry is 
characterized by low productivity arising from 
such constraints as diseases, predation, poor 
management and marketing strategies 
(Kisungwe et al., 2012). The major diseases 
affecting FRLC include the devastating 
Newcastle Disease (ND), Infectious Bursa 





Disease (IBD, Gumboro) among the viral 
diseases and fowl typhoid, callibacillosis 
among bacterial diseases (Moreki, 2013). 
Interventions towards control of these diseases 
have mostly involved the use of vaccines, 
which are practically inaccessible and 
expensive to the poor rural villagers. Hence, 
many people in the villages resort to the use of 
the cheap and easily available ethnoveterinary 
plants (Waihenya et al., 2002; Adejeji et al., 
2013; Moreki, 2012; Moreki, 2013). The 
evidence and importance of plant-based 
natural products in the treatment and control 
of poultry viral diseases has been reported 
(Waihenya et al., 2002; Bakari et al., 2012; 
Bakari et al., 2013; Mabiki et al., 2013), 
calling for more research endeavors to the 
untapped biomedical potential of bio-
resources endowment of tropical and 
subtropical floral diversity.  
In our recent papers, we reported the 
isolation of a series of novel bioactive 
aminocinnamoyl tetraketides (Samwel et al., 
2011), a new glucosylglycero-N octenyl 
adipate and a known glycoflavonoid afzelin 
from the leaf extracts (Nyandoro el al., 2012) 
of the red-listed endangered medicinal plant 
Toussiantia orientalis Verdc. (EAM-CF-
CEPF-PAP, 2009), several aristolactams, a 
pseudo-nucleoside 1-(2-C-methyl-β D-
ribofuranosyl)-uracil and other bioactive 
metabolites from the stem and root bark 
extracts of the same plant species (Odalo et 
al., 2010). These results inspired us to include 
the recently described and red-listed 
endangered Toussaintia species, namely 
Toussaintia patriciae Q. Luke & Deroin 
(Deroin and Luke 2005) in the phytochemical 
investigations to supplement the existing 
chemical information on the constituents of 
the genus Toussaintia and to further assess 
effectiveness of the metabolites isolated there 
from on poultry viruses. In the analysis, the 
leaf extracts of T. patriciae did not yield any 
of the metabolites that were previously 
obtained from T. orientalis, instead ursolic 
acids and ethyl gallate were obtained. The 
metabolites from T. patriciae together with 
the recently reported aminocynnamoyl 
tetraketides from T. orientalis were evaluated 
for their in ovo antiviral activity against the 
two poultry viruses; the Infectious Bursal 
Disease Virus (IBDV) and Newcastle Disease 
Virus (NDV) that are economically important 
to the poultry industry in many countries, 
Tanzania included.  
 
MATERIALS AND METHODS  
Plant materials collection 
The leaves of Toussaintia patriciae Q. 
Luke & Deroin were collected on 4th June 
2008 from Ndundulu Forest Reserve, 12 km 
from Udekwa Village, Kilolo District in Iringa 
Region, Tanzania. The plant species was 
authenticated at the Herbarium of the 
Department of Botany, University of Dar es 
Salaam where a voucher specimen is 
preserved (# FMM 3521). 
 
Extraction, isolation and identification 
compounds 
The air-dried and powdered leaves (1.4 
kg) of T. patriciae were subjected to 
sequential extraction using petroleum ether, 
dichloromethane (CH2Cl2) and ethanol 
(CH3CH2OH, EtOH) at room temperature, 
each soaking lasting for 48 h so as to obtain 
less, medium and polar constituents of the 
plant materials, respectively. Removal of 
residual solvent under reduced pressure in a 
rotavap furnished the crude extracts. The pet 
ether and CH2Cl2 extracts were obtained in 
small quantities which did not show any 
interesting spots on thin layer chromatography 
(TLC) [Precoated plates (Merck, Kieselgel 60 
F254, 0.20 mm)]. Hence, the extracts were not 
analysed further. The EtOH extract was 
obtained as a dark green gelatinous material 
(18.2 g), whose TLC analysis showed one 
conspicuous UV positive spot and other three 
UV negative spots [UV/VIS (254 and 365 nm) 
and anisaldehyde spray reagent/heat at ca 110 
ºC]. EtOH extract was subjected to a repeated 
chromatographic separation (Silica gel 60 
(Merck 230–400 mesh, 10–100% Ethylacetate 
(EtOAc)/pet ether gradient) followed by gel 





filtration (Sephadex LH-20, 1:1 
MeOH/CH2Cl2) to isolate the compounds.  
Chemical structures of the isolated 
compounds were identified upon analysis of 
their spectroscopic [1H- (300 MHz) and 13C-
NMR (75 MHz): Bruker Topspin 
Spectrometer and CD3OD or DMSO-d6 as 
deuterated solvent, TMS as internal standard 
for 1H-NMR and solvent signal for 13C-NMR] 
and spectrometric data [high-resolution 
electron ionisation mass spectra (HREIMS): 
GCT Premier TOF mass spectrometer, 70 eV 
and 180 ºC source temperature]. 
 
In ovo antiviral assays 
Allantoic cavity inoculation assay 
The embryonated eggs collected from 
healthy flocks were used for the determination 
of antiviral activity of the isolated natural 
products against IBDV (KMRG-48 strain) and 
velogenic NDV strain (13C/SUA). Both viral 
strains used in the experiment were supplied 
by the Department of Microbiology and 
Parasitology, Sokoine University of 
Agriculture and they originated from field 
outbreaks. The exterior surface of fertilized 
eggs were sterilized with 70% ethanol and 
incubated for 9 days at 37 ºC and 65-70% 
humidity in an egg incubator (Memmert 854, 
Schwabach, Germany) prior to inoculation. 
The nine-day-old embryonated eggs were 
used for the antiviral testing through the 
allantoic cavity route of inoculation (Hsiung 
1973). The eggs were candled to confirm their 
fertility and a small puncture was made 
through the shell over the air sac as previously 
described by Grimes (2002). The stock 
solutions containing the tested compounds 
were prepared by dissolving each sample (2 
mg) in dimethylsulphoxide (DMSO, 5 ml) to 
make a solution of 0.4 mg/ml concentration. 
The tested compounds were mixed with the 
viral strains and allowed to equilibrate for 30 
min. before inoculation. The eggs were 
inoculated with the specimen [0.1 mL, having 
been prepared by mixing tested compound 
(0.9 ml) with the viral strain (0.1 ml) in 
allantoic fluid treated with the antibiotic 
Gentamycin to make up a concentration of 
360 µg/ml of the tested sample], using a 
sterile insulin needle and syringe. The 
inoculated site of the shell was sealed with 
paraffin wax and each egg was dated and 
labeled. For each set of the tested compound, 
five eggs were used per specimen (compound 
+ virus), and three sets of controls were 
employed [egg control (eggs without any 
inoculums) acting as a negative control, 
solvent control (DMSO + virus) and virus 
control (virus only) acting as a positive 
control. The eggs were then incubated at 37 
ºC and 65-70% humidity for 72 and 96 h for 
IBDV and NDV, respectively.  
The eggs were candled after every 24 h 
to monitor embryonic development and 
survival. The egg shells were then opened 
after 72 or 96 h of incubation to record 
mortality, survival, embryo size, weight, and 
organ formation. The specimen treated 
embryos were then compared and contrasted 
with the control sets in relation to survival, 
embryo size, weight, and completeness in 
tissue/organ formation. Furthermore, InStat 3 
statistical package was used to compare the 
logarithm of the mean weight of the egg 
control (negative control) with those of the 
untreated virus-infected-embryos (positive 
control) and the treated embryos (compound + 
virus). 
Viral haemagglutination inhibition test 
In case of NDV assay, the allantoic fluid 
from the sample treated specimens and control 
eggs were further harvested to determine viral 
infectivity. The haemagglutination inhibition 
test was carried out as previously described by 
Allan and Gough (1974). A phosphate buffer 
solution (PBS, 25 µL) was placed in each well 
of the microtitre plate. Then allantoic fluids 
(25 µL each) from negative and positive 
controls and treated specimens (virus + tested 
compound) were added to the 1st well of 
column 1, and each thoroughly mixed.  A two 
fold serial dilution was done by transferring 
25 µl of the suspension to the next well and 
the last one discarded. The 25 µl of 1% 
chicken RBCs in 99% PBS was added to each 





well of the microtitre plate. The microtitre 
plate was shaken, covered and incubated at 
room temperature for about 30 min. The 
results were observed to see whether there 
was haemagglutination or not, and the lowest 
titre values were recorded at the end point 
beyond which there was no further 
haemagglutination. 
IBDV being inactive in 
haemaglutination inhibition test and having no 
other test kits available at our exposal to 
quantitate IBDV antibodies during the 
investigation reported hereby, no attempt was 
made to establish the presence of IBDV 
following infection of the embryos. 
 
RESULTS  
Isolation and identification of compounds 
Isolation and structural elucidation for 
compounds 1-7 (Figure 1) from T. orientalis 
is reported in our recent papers (Samwel et al., 
2011; Nyandoro et al., 2012). Repeated 
chromatography of the leaf ethanol extract of 
Toussaintia patriciae yielded  ursolic acid (8) 
(Budzikiewicz et al., 1963; Seebacher et al., 
2003), its hydroxyl derivatives 30-
hydroxyursolic acid (9) (Budzikiewicz et al., 
1963; Talapatra et al., 1981; Woo et al., 1984) 
and 19α,23-dihydroxyursolic acid (10) 
(Budzikiewicz et al., 1963; Soares et al., 
1998), together with ethyl gallate (ethyl 3,4,5-
trihydroxybenzoate, 11) (Ooshiro et al., 2009) 
(Figure 2). Structures of the isolated 
compounds were established based on 
analysis of both 1 & 2D spectroscopic as well 
as spectrometric data, which were consistent 
with those reported in the literature.  
In ovo antivirial activity 
When evaluated for the in ovo antiviral 
activity at a concentration of 360 µg/ml, the 
compounds demonstrated effective control of 
viral virulence at different levels of 
significance, with the nitrogenous compounds 
and  and the glycosylflavonoid 7 isolated from 
T. orientalis exhibiting significant antiviral 
activity. These compounds effectively 
controlled the IBDV activity and enabled the 
embryo to grow to normal size with complete 
organ formation (Table 1). The mean weights 
of chicken embryos treated with each of these 
compounds showed no significance difference 
when compared with the mean weights of 
uninfected embryos (Table 2). However, 
compounds 3, 5 and 6, also isolated from T. 
orientalis showed insignificant activity 
against IBDV, with compound 6 being the 
least active. Furthermore, compounds 1-7 
demonstrated antiviral activity against NDV 
by enabling the treated chicken embryos to 
grow to normal size and to complete organ 
formation (Table 3). However, the mean 
weights of embryos treated with each of these 
compounds against NDV were either very or 
highly significant compared to uninfected 
ones, indicating that the treatment was less 
effective (Table 4).  
The ursane-type triterpenoids 8-10 as 
well as ethyl gallate (11) isolated from T. 
patriciae also showed high antiviral potency 
against IBDV. Thus, while the untreated 
chicken embryos died within 24 h of 
inoculation, the embryos treated with 
compounds 8-11 survived, and grew to normal 
size with complete organ formation similar to 
the uninfected embryos (Table 5). Compounds 
9 and 10 were particularly effective against 
IBDV, with the mean weights being 
comparable to those of uninfected embryos, 
indicating effectiveness of the treatment 
(Table 6). Although compounds 8-11 also 
exhibited antiviral activity against NDV by 
enabling the treated chicken embryos to grow 
to normal size and to complete organ 
formation (Table 7), the difference in the 
mean weights of embryos treated with these 
compounds compared to the uninfected ones 
ranged from very to highly significant (Table 
8), which meant that the treatment was less 
effective against this virus.   
The haemagglutination inhibition test 
for NDV was used as an alternative method to 
evaluate the antiviral effect of the isolated 
compounds by generating viral titre values, 
which showed the extent to which the virus 





was cleared after treatment. The results from 
the haemagglutination test as were observed 
in the microtitre plate assays are represented 
in Table 9. Thus, on the basis of viral titre 
reduction, ethyl gallate (11) had the lowest 
titre value (1:16) followed by 
glycosylflavonoid 7 (1:32), while the other 
compounds had viral titre values of 1:128 and 
1:256. These values were by far lower (128, 
64, 16, or 8 times, respectively) than for the 
positive control (1:2048), indicating 
effectiveness of the compounds against NDV.
 
 























any inoculums)  
Alive Alive Alive Alive Alive Normal 7.626 Complete 
Solvent control 
(Virus +DMSO) 
Dead Dead Dead Dead Dead Abnormal 1.670 Incomplete 
Positive control 
(Virus alone) 
Dead Dead Dead Dead Dead Abnormal 1.647 Incomplete 
Virus + 1  Alive Alive Alive Alive Alive Normal 6.939 Complet  
Virus + 2 Alive Alive Alive Alive Dead Normal 6.921 Complete 
Virus + 3 Alive Alive Alive Alive Alive Normal 7.309 Complete 
Virus + 4 Alive Alive Alive Dead Alive Normal 6.908 Complete 
Virus + 5 Alive Alive Alive Alive Alive Normal 6.564 Complete 
Virus + 6 Dead Dead Dead Dead Dead Abnormal 2.464 Incomplete 
Virus + 7 Alive Alive Alive Alive Alive Normal 7.720 Complete 
 
 
Table 2: Comparison of the logarithm of the mean weight of untreated (infected with IBDV), 
treated (with compounds from Toussaintia orientalis) against uninfected embryos (Mean ± SEM = 
0.882 ± 0.004). 
 
Treatment Mean ± SEM T-value P-value 95 % CL Comment 
IBDV only 0.215 ± 0.020 32.512 < 0.0001 0.159-0.270 Highly significant 
Virus + 1  0.837 ± 0.033 1.386 0.1015 0.745-0.927 Not significant 
Virus + 2 0.837 ± 0.026 1.679 0.0659 0.076-0.911 Not significant 
Virus + 3  0.845 ± 0.011 3.079 0.0076 0.814-0.876 Very significant 
Virus + 4 0.862 ± 0.022 0.8993 0.1974 0.799-0.924 Not significant 
Virus + 5 0.813 ± 0.003 12.565 < 0.0001 0.805-0.823 Highly significant 
Virus + 6  0.349 ± 0.098 5.436 0.0003 0.077-0.620 Highly significant 
Virus + 7 0.887 ± 0.008 0.5415 0.3014 0.864-0.911 Not significant 
Note: Level of significance, α = 0.05 [Not significant (p ≥ 0.05), significant (p < 0.05), very significant (p < 0.01), 
highly significant (p < 0.001)]. 
 
 





Table 3:  Antiviral activity (at 360 µg/ml) of compounds from Toussaintia orientalis against NDV. 
 






Embryo  organ 
formation 
Negative control 
(Eggs without any 
inoculums)  
Alive Alive Alive Alive Alive Normal 9.438 Complete 
Positive control 
(Virus +DMSO) 
Dead Dead Dead Dead Dead Abnormal 3.837 Incomplete 
Positive control 
(Virus alone) 
Dead Dead Dead Dead Dead Abnormal 3.204 Incomplete 
Virus + 1 Alive Alive Alive Alive Alive Normal 6.206 Complete 
Virus + 2 Alive Alive Alive Alive Alive Normal 6.734 Complete 
Virus + 3 Alive Alive Alive Alive Alive Normal 6.656 Complete 
Virus + 4 Alive Alive Alive Alive Alive Normal 6.372 Complete 
Virus +5 Alive Alive Alive Alive Alive Normal 6.227 Complete 
Virus + 6 Alive Alive Alive Alive Alive medium 5.000 Complet 




Table 4: Comparison of the logarithm of the mean weight of untreated (infected with NDV), treated 
(with compounds from Toussaintia orientalis) against uninfected embryos (Mean ± SEM = 0.972 ± 
0.026). 
 
Treatment Mean ± SEM T-value P-value 95 % CL Comment 
NDV only 0.505 ± 0.015 16.171 < 0.0001 0.463-0.546 Highly significant 
Virus + 1  0.792± 0.015 6.003 0.0002 0.754-0.833 Highly significant 
Virus + 2 0.827 ± 0.013 4.965 0.0006 0.792-0.863 Highly significant 
Virus + 3  0.804 ± 0.011 5.919 0.0002 0.772-0.836 Highly significant 
Virus + 4 0.822 ± 0.013 5.069 0.0005 0.784-0.861 Highly significant 
Virus + 5 0.794 ± 0.007 6.611 < 0.0001 0.805-0.823 Highly signif cant 
Virus + 6 0.699 ± 0.005 10.250 < 0.0001 0.684-0.714 Highly significant 




Table 5: Antiviral activity (at 360 µg/ml) of compounds from Toussaintia Patriciae against IBDV. 
 





Embryo  organ 
formation 
Virus + 8 Alive Alive Dead Alive Alive Normal 8.418 Complete 
Virus + 9 Alive Alive Alive Alive Alive Normal 7.971 Complete 
Virus + 10  Dead Alive Alive Alive Alive Normal 7.159 Complete 
Virus +11 Alive Alive Alive Alive Alive Normal 8.218 Complete 
 





Table 6: Comparison of the logarithm of the mean weight of untreated (infected with IBDV), 
treated (with compounds from Toussaintia patriciae) against uninfected embryos (Mean ± SEM = 
0.882 ± 0.004). 
 
Treatment Mean ± SEM T-value P-value 95 % CL Comment 
IBDV only 0.215 ± 0.020 30.618 < 0.0001 0.159-0.270 Highly significant 
Virus + 8 0.924 ± 0.015 2.772 0.0121 0.884-0.965 Significant 
Virus + 9 0.900 ± 0.014 1.229 0.1270 0.861-0.960 Not significant 
Virus + 10  0.924 ± 0.018 1.562 0.0784 0.803-0.903 Not significant 
Virus + 11 0.914 ± 0.013 2.273 0.0263 0.877-0.951 Significant 
 
 
Table 7: Antiviral activity (at 360 µg/ml) of compounds from Toussaintia patriciae against NDV. 
 






Embryo  organ 
formation 
Virus + 8 Alive Alive Dead Alive Alive Normal 7.004 Complete 
Virus + 9 Alive Alive Alive Alive Alive Normal 5.926 Complete 
Virus + 10  Alive Alive Alive Alive Alive Normal 7.075 Complet  
Virus + 11 Alive Alive Alive Alive Alive Normal 7.518 Complete 
Note: Control results the same as for Table 3 
 
Table 8: Comparison of the logarithm of the mean weight of untreated (infected with NDV), treated 
(with compounds from Toussaintia patriciae) against uninfected embryos (Mean ± SEM = 0.826 ± 
0.013). 
 
Treatment Mean ± SEM T-value P-value 95 % CL Comment 
NDV only 0.505 ± 0.015 15.573 < 0.0001 0.463-0.546 Highly significant 
Virus + 8 0.846± 0.003 4.831 0.0007 0.855-0.852 Highly signif cant 
Virus + 9 0.827 ± 0.013 6.299 0.0001 0.720-0.822 Highly significant 
Virus + 10  0.849 ± 0.003 4.662 0.0008 0.843-0.857 Highly significant 
Virus + 11 0.876 ± 0.004 3.622 0.0034 0.864-0.888 Very signifcant 
 
 







Well # Titre  
Negative control 
(Eggs without any inoculums)  
-ve -ve -ve Virus + 5 +ve 8 1:256 
Positive control (NDV alone) +ve 11 1:2048 Virus + 6 +ve 8 1:256 
Solvent control (NDV +DMSO) +ve 10 1:1024 Virus + 7 +ve 5 1:32 
Virus + 1 +ve 8 1:256 Virus + 8 +ve 7 1:128 
Virus + 2 +ve 8 1:256 Virus + 9 +ve 8 1:256 
Virus + 3 +ve 8 1:256 Virus+ 10 +ve 7 1:128 
Virus + 4 +ve 8 1:256 Virus + 11 +ve 4 1:16 












































































Figure 1: Compounds isolated from Toussaintia orientalis (1–7). 
 
11
8: R1 = R2 = R3 = H
9: R1 = R2 = H, R3 = OH


















The results of the antiviral assays as 
presented in these investigations have 
demonstrated the compounds isolated from 
Toussantia orientalis and T. patriciae to have 
activity against the two tested avian viruses, 
albeit with unequal efficacy. Whereas the 
tetraketide nitrogenous compounds 1, 2 and 4 





and the glycosylflavonoid 7 isolated from T. 
orientalis, and ursolic acid derivatives 9 and 
10 obtained from T. patriciae exhibited 
significant activity against IBDV, the other 
compounds showed moderate or weak 
activity. Generally, the tested compounds 
were more potent to IBDV than NDV. The 
observed differences in activity against the 
two assayed viruses and between the 
compounds tested could probably be 
attributed to structural differences hence the 
corresponding different modes of action of the 
compounds against the tested viruses. Thus, 
the compounds could have virucidal, 
inhibitory or combinations of both effects.  
The nitrogenous compounds with 
nitrogen sandwiched between two carbonyl 
groups as in 1 and 2, or with electronegative 
oxygen and a carbonyl group as in 3 and 4 
showed better activity than 5 that lacks a 
heterocyclic atom-containing fused ring. Such 
a structural-activity trend could be attributed 
to the variation in the degree of 
electrophilicity of the N-atom adjacent to 
electron withdrawing species (carbonyl group 
and oxygen), making the corresponding 
compounds to react at different rates with 
nucleophilic targets in the viral protein coat or 
nucleoside.  
The triterpenoids 8 - 10 have some 
similarities in their structural features; that is, 
each has a hydroxyl group at C-3, a C12- 13 
double bond and a carboxylic acid group at C-
17. The compounds differ only in the extra 
hydroxylation at C-30 for 9, C-19 and C-23 
for 10. Thus, the higher antiviral efficacy of 
compounds 9 and 10 as compared to 8 could 
have been due to the extra hydroxylation in 
the first two compounds. In fact, ursolic acid 
(8) and its derivatives similar to 9 and 10 are 
well known for their antiviral properties, 
which in most cases has been associated with 
the presence of an oxo- and hydroxyl-
functionalities (Sun et al., 2006), as further 
corroborated in the present studies for the 
tested avian viral strains. On the other hand, 
alkyl gallates such as 11 are also known for 
their virucidal and inhibitory effects against 
viruses, particularly Herpes Simplex Virus 
(HSV). The previous structure activity 
relationship (SAR) studies of n-alkyl gallates 
indicated the three hydroxyl units and the 
alkyl group to play a role in the antiviral 
potency of such compounds (Kratz et al., 
2008). Therefore, the same structural features 
could have also attributed to the observed 
antiviral activity of compound 11 reported in 
these investigations.  
Although the viral load reduction and 
virulence control was evident as indicated by 
titre values (for NDV) and embryo survival, 
normal size, complete organ formation, and 
mean weights of chicken embryos treated with 
some compounds showing no significance 
difference as compared with uninfected 
embryos, the mode of action, elucidation of 
the exact target sites of the active compounds 
and their toxicity remains a subject of future 
research. Nevertheless, the in ovo antiviral 
results hereby reported indicate that the two 
Toussaintia species accumulate metabolites 
that are potential leads for the development of 
antiviral agents against IBDV and NDV. The 
results further underscore the need for the 
concerted efforts to conserve these bio-
resources vulnerable to extinction. 
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